---
figid: PMC11899884__ijms-26-01868-g001
figtitle: PI3K/AKT/mTOR pathway in Cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11899884
filename: ijms-26-01868-g001.jpg
figlink: /pmc/articles/PMC11899884/figure/F1/
number: F1
caption: The PI3K/AKT/mTOR pathway in Cancer. After a growth factor binds to its receptor,
  the route activates Class I phosphoinositide 3-kinases. Receptor tyrosine kinases
  activate Class IA PI3K, while G-protein-coupled receptors activate Class IB. Both
  classes convert PIP2 into PIP3, which recruits and activates plasma membrane AKT.
  Activated AKT phosphorylates and suppresses TSC1/2, a negative regulator of mTORC1.
  This blockage activates mTORC1, a protein synthesis, cell metabolism, and growth
  master regulator. The mTORC1 complex boosts translation and cancer growth, proliferation,
  and survival. The mechanism also aids cancer migration and metastasis. The figure
  was created using the BioRender.com online commercial platform
papertitle: A Comprehensive Review of Nanoparticle-Based Drug Delivery for Modulating
  PI3K/AKT/mTOR-Mediated Autophagy in Cancer
reftext: Md Ataur Rahman, et al. Int J Mol Sci. 2025 Mar;26(5).
year: '2025'
doi: 10.3390/ijms26051868
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: nanoparticles | drug delivery | PI3K/AKT/mTOR | autophagy | cancer therapy
  | targeted therapy
automl_pathway: 0.9187415
figid_alias: PMC11899884__F1
figtype: Figure
redirect_from: /figures/PMC11899884__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11899884__ijms-26-01868-g001.html
  '@type': Dataset
  description: The PI3K/AKT/mTOR pathway in Cancer. After a growth factor binds to
    its receptor, the route activates Class I phosphoinositide 3-kinases. Receptor
    tyrosine kinases activate Class IA PI3K, while G-protein-coupled receptors activate
    Class IB. Both classes convert PIP2 into PIP3, which recruits and activates plasma
    membrane AKT. Activated AKT phosphorylates and suppresses TSC1/2, a negative regulator
    of mTORC1. This blockage activates mTORC1, a protein synthesis, cell metabolism,
    and growth master regulator. The mTORC1 complex boosts translation and cancer
    growth, proliferation, and survival. The mechanism also aids cancer migration
    and metastasis. The figure was created using the BioRender.com online commercial
    platform
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - PIK3CA
  - CUX1
  - SART3
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PTEN
  - IMMT
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPTOR
  - DEPTOR
  - TSC1
  - CCL26
  - TSC2
  - AKT1S1
  - ATP6V1B2
  - Raptor
  - Cancer
---
